Measuring hsCRP: The inflammation marker that reassesses your heart risk

Standard CRP tests miss low-level inflammation that can still raise heart risk. High-sensitivity CRP makes it visible — and is part of an important group of markers that goes far beyond the acute infection.

Standard CRP and hsCRP: What is the difference?

CRP (C-reactive protein) is a protein the liver produces in response to inflammatory signals. The standard CRP used in routine diagnostics reliably detects acute inflammation from around 5 to 10 mg/l — such as occurs during infections or after injuries. More interesting for the long-term perspective is high-sensitivity CRP (hsCRP): it measures values from 0.1 mg/l, making low-level inflammation visible that remains invisible in the standard test.

For cardiovascular risk, a widely used classification proposed by the American Heart Association applies: an hsCRP below 1.0 mg/l is considered favourable, 1.0 to 3.0 mg/l as intermediate risk, and above 3.0 mg/l as elevated risk. These thresholds apply to measurements taken outside acute infection phases — anyone currently unwell should wait until after recovery before testing.

What hsCRP tells you about your heart risk

One of the most influential findings came from a study published in the New England Journal of Medicine in 2000: in women without known heart disease, hsCRP was a stronger predictor of later cardiovascular events than LDL cholesterol. Since then, large observational studies have confirmed that hsCRP is an independent risk factor — independent of cholesterol, blood pressure and smoking.

This does not mean that elevated hsCRP inevitably leads to a heart attack. It means that a chronic state of low-level inflammation in the body gradually puts strain on the vascular system. For people with intermediate heart risk, where standard markers alone do not allow a clear assessment, hsCRP can sharpen the picture and make the conversation with a doctor more concrete.

Further inflammation markers: IL-6, fibrinogen and ESR

Interleukin-6 (IL-6) is a signalling molecule that prompts the liver to produce CRP. IL-6 rises earlier than hsCRP during inflammatory processes and is well established in research, though less commonly available in routine diagnostics. Fibrinogen is a clotting protein that also serves as an inflammation marker: elevated fibrinogen levels are associated with atherothrombotic events.

The erythrocyte sedimentation rate (ESR) is one of the oldest inflammation markers and is occasionally measured as a non-specific screening tool. It rises in many conditions and is less precise than hsCRP, but can be helpful in the overall picture. For a longevity-oriented inflammation panel, the combination of hsCRP and fibrinogen is a practical starting point available in most laboratories.

What influences hsCRP — and what does not

Smoking, excess weight — especially visceral fat — and lack of exercise measurably increase hsCRP. Conversely, regular physical activity demonstrably lowers the value. A fibre-rich, Mediterranean diet is also associated with lower hsCRP levels in the research literature.

Important for interpretation: a measurement taken during or shortly after an infection does not provide a meaningful result. hsCRP rises sharply with any acute illness. For a valid longevity measurement, the test should be done in a healthy resting state, and two to three measurements over several weeks are more meaningful than a single value.

Interpreting hsCRP correctly: context beats a single value

An elevated hsCRP explains nothing on its own. It shows that inflammatory signals are active — not where or why. Possible causes include undetected sleep apnoea, periodontitis, elevated body fat percentage, insulin resistance, or autoimmune processes. A persistently elevated value is therefore a reason to work with your doctor to look for possible causes.

Combined with a lipid profile, blood pressure, body composition and lifestyle, hsCRP provides a clearer overall picture. The measures that make sense when hsCRP is elevated due to excess weight differ from those indicated for sleep deprivation or smoking. Diagnostics are a starting point — not a diagnosis.

Tracking inflammation markers over time with the YUTHI app

In the YUTHI app, you can log hsCRP, fibrinogen and other inflammation markers after each blood test. Because trends tell more than a single value, the app lets you see at a glance whether an elevated hsCRP has improved after a lifestyle change — a concrete signal you can bring to your next doctor's appointment.

Sources

• Ridker PM et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 2000;342(12):836–843.
• Danesh J et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 2004;350(14):1387–1397.
• Pearson TA et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation, 2003;107(3):499–511.
• Ridker PM. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circulation Research, 2016;118(1):145–156.